GPT and Hepatic failure: In total, 38.7% of patients experienced serious TEAEs and 16.1% reported serious TEAEs related to TAK-164, which included nausea, vomiting, pyrexia, hepatic failure, acute kidney injury, ALT increased, blood bilirubin increased, and platelet count decreased (each n = 1).